Big Pharma delivered strong Q4 2025 results, with most companies beating revenue and EPS expectations and providing generally solid 2026 guidance. Eli Lilly solidified its leadership in obesity and ...

Learn about osteoporosis, its risks, symptoms, and prevention strategies to maintain bone health and prevent fractures.

Millions of men are living with undiagnosed bone disease, putting them at risk of life-threatening fractures, experts have ...

(Corrects paragraph 5 in February 5 story to say 2025 Prolia sales were $4.4 billion, not $1.05 billion) Feb 5 (Reuters) - ...

Over the weekend, Neel Somani, who is a software engineer, former quant researcher, and a startup founder, was testing the math skills of OpenAI’s new model when he made an unexpected discovery. After ...

Amateur mathematicians are using artificial intelligence chatbots to solve long-standing problems, in a move that has taken professionals by surprise. While the problems in question aren’t the most ...

Teva delivers 3 consecutive years of growth - 2025 revenues of $17.3 billion, an increase of 4% year-over-year (YoY) in U.S.

Science and society collaboration is essential for scientific progress, especially in the health and biomedical fields where basic researchers, clinicians and patients are involved, as shown by the ...

Alvotech (NASDAQ: ALVO), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that ...

Amgen (NASDAQ: AMGN) today announced financial results for the fourth quarter and full year of 2025 versus the ...

The most dangerous part of AI might not be the fact that it hallucinates—making up its own version of the truth—but that it ceaselessly agrees with users’ version of the truth. This danger is creating ...